COMBINATION PRODUCT DEVELOPMENT

A comprehensive Product Development Process was created and customized for a pharmaceutical company engaged in new product development of combination products (drug/device) considering new rule released by FDA for combination products (21CFR Part 3); Completed audit of new, draft, Design Control procedures and completed authoring of updates. Multiple client engagements were completed in this area.